Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights

Go back to Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights
(NASDAQ: LTRN) Delayed: 1.50 --0 (-0%)
Previous Close $1.50    52 Week High
Open $1.50    52 Week Low
Day High $1.50    P/E N/A 
Day Low $1.50    EPS
Volume 1,028